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Abstract
AIM: To confirm the presence of recombination, full-
length hepatitis B virus (HBV) from chronic patients 
was sequenced and analyzed.
METHODS: Full-length HBV genomes from 12 patients 
were amplified and sequenced in an automated 
sequencer. Phylogenetic analysis was carried out on 
full-length, Core and preS2/Surface regions using 
MEGA software. SimPlot Boot Scanning and amino acid 
sequence analysis were performed for confirmation of 
recombination.
RESULTS: Eight patients were infected with genotype D 
strain; one patient with genotype A and three patients 
had genotype A and D recombination; two of them 
had cirrhosis and one had hepatocellular carcinoma. 
Phylogenetic analysis of core and preS2/surface 
regions separately showed evidence of genotype A and 
D recombination. The breakpoints of recombination 
were found to be at the start of preS2 and at the end 
of surface coding regions.
CONCLUSION: We identified and characterized 
recombinant A and D genotype HBV in hepatitis B 
surface antigen (HBsAg)-positive patients.
© 2008 The WJG Press. All rights reserved.
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INTRODUCTION
Hepat i t i s B v i r us (HBV) i s an org an- spec i f i c 
virus causing inflammation of  the liver, leading to 
complications such as chronic liver disease (CLD) 
and hepatocellular carcinoma (HCC). As compared to 
Europe and North America, the prevalence of  HBV 
infection in Asia is quite high, with 40 million people 
harboring chronic HBV infection in India[1].
Two features make HBV unique. First, its way of  
replication, by which it uses the pregenomic RNA as 
an intermediate step for reverse transcription. Second, 
the efficient utilization of  its compact genome for 
production of  seven different proteins from four open 
reading frames (ORFs). Major proteins that are encoded 
from these four ORFs are the envelope, core the X 
protein and the polymerase.
Nucleotide substitution, deletion, insertion and 
recombination are the main factors that results in 
variation of  the HBV genome. HBV genotypes are 
classified into eight genotypes, from A to H, based 
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on the inter-group divergence of  8% or more in the 
complete genome nucleotide sequence, or a 4% or 
greater divergence of  the Surface gene[2-4]. Recent studies 
have reported recombination between the HBV genomes 
of  two genotypes. Two kinds of  HBV genotype B 
have emerged[5-7] i.e. recombinant with genotype C and 
without recombination with C. Mixed genotype refers 
to an infection that contains more than one genotype 
in the same patient and is usually the result of  multiple 
exposures and super-infection, the complete genome 
of  each strain belongs to one genotype. According to 
Robertson et al[8], recombination can be detected when 
different genes or different regions within the same 
gene are placed by phylogenetic analysis into different 
sequence subtypes.
We and others from India have reported the presence 
of  mixed genotype A and D[9-12]. However, despite the 
presence of  mixed genotypes, there are no reports from 
India about the presence of  recombination, especially 
using the full-length HBV genome sequencing approach.
In the present study, we have identified recombinant 
genotype A and D in patients with CLD and HCC due 
to chronic HBV infection.
MATERIALS AND METHODS
Patients and serological markers
Twelve treatment-naive chronic HBV infected patients 
[five with cirrhosis, five with chronic hepatitis B 
(CHB), and two with HCC] were enrolled. The serum 
from these patients was tested for the presence of  
hepatitis B surface antigen (HBsAg) by ELISA (Abbot 
Laboratories, North Chicago, USA and Organon 
Tecknika, Boxtel, Netherlands). In addition, the serum 
was tested for hepatitis e antigen (HBeAg), antibody to 
hepatitis e antigen (anti-HBe), hepatitis B core Antigen 
(IgG anti-HBc) by ELISA (Organon Tecknika, Boxtel, 
Netherlands). Assessment of  the severity of  liver disease 
was made by Child-Pugh score[13]. Approval of  the 
institutional ethical committee was obtained to undertake 
this study.
HBV DNA quantitation
HBV DNA was quantified by a commercially available 
hybrid capture assay (Ultra sensitive kit, Digene, USA) 
with the lower limit of  detection being 4700 copies/mL.
Full-length HBV DNA amplification
HBV DNA was extracted by using 0.5 to 1.0 mL of  
patient’s plasma using Sera Lysis Buffer (10 mmol/L 
Tris, 5 mmol/L EDTA, 50 mmol/L NaCl), SDS (1%) 
and proteinase K (1 mg/mL), followed by extraction 
with Tris-saturated phenol (pH 7.9) chloroform and 
then precipitation with ethanol. The obtained pellet 
was dried and dissolved in 30 µL of  1 × TE buffer 
(10 mmol/L Tris 1 mmol/L EDTA), a method described 
previously[12]. Full-length HBV DNA amplification was 
done by polymerase chain reaction (PCR), as described 
by Gunther’s method[14]. The Taq polymerase with DNA 
proof  reading activity was used. (Expand high fidelity 
Taq-Polymerase Roche GmBH Basel, Switzerland). 
Primers were: P1-CCGGAAAGC TTGAGCTCTTC
TTTTTCACCTCTGCCTAATCA (1821-1841), P2-
CGGAAAGCTTGAGCTCTTCAAAAAGTTGCA 
TGGTGCTGG (1823-1806). The reaction conditions 
for PCR were 94℃ for 5 min, 94℃ for 1 min, 60℃ 
for 1.5 min; 68℃ for 7 min and extension at 72℃ for 
10 min, 35 cycles were performed. Purified full-length 
HBV DNA from recombinant vector pCF 80 (Tetramer 
of  3.2 kb HBV cloned in pBR322) was used as a positive 
control. DNA extracted from serum samples of  healthy 
individuals and commercially available molecular biology 
grade water served as the negative control. Every set of  
PCR amplifications included HBV-positive and-negative 
controls. Primers were designed using the software 
Primer Express.
Sequencing full-length HBV genomes
PCR-amplified products were purified using the Qiagen 
Gel purification kit according to their recommended 
protocol. Internal primers used for sequencing given in 
Table 1 were used for sequencing in an automated DNA 
sequencer (ABI Prism 3730 Applied Biosystems, Foster 
City, USA). The nucleotide sequence data reported 
in this paper appears in the GenBank/EMBL/DDBJ 
nucleotide sequence databases with accession numbers 
EF103275-EF103285 and AY945305. The genome 
length has been measured according to Galibert et al[15].
Data analysis
HBV genotyping was done by phylogenetic analysis 
using full- length sequences, core and preS2 and 
surface regions. Briefly, sequences were aligned using 
the CLUSTALW software[16]. Phylogenetic trees 
were constructed using the Kimura two-parameter 
matrix and neighbor-joining (NJ) method by MEGA 
software version 3.1[17]. To confirm the reliability of  
the phylogenetic tree analysis, bootstrap resampling 
and reconstruction were carried out 1000 times. 
Recombinat ion was invest ig ated by S imPlot [18] 
distributed by the author Ray at (http://www.welch.jhu.
edu/). Boot scanning was performed for each of  the 
strains using four sequences at a time[19], i.e. putative 
recombinant sequence, two consensus sequences of  
the parental genotype and one consensus sequence as 
an out-group.
Table 1  Primers used for sequencing





SEQ_F4 5-CTTCCTGCTGGTGGCTCCAGTTC-3       (53-75)
SEQ_F5 5-CTCGTGGTGGACTTCTCTC-3       (253-272)
SEQ_F6 5-ATCCTCAACCACCAGCACG-3       (492-510)




Chauhan R et al . Recombinant Indian HBV genotype                                                                                  6229
www.wjgnet.com
RESULTS 
Patients and virological characteristics
Baseline characteristics of  the study population are 
given in Table 2. The majority of  the patients were male 
(M: 10, F: 2). Of  the 12 patients, five had cirrhosis, 
all diagnosed radiologically; [one decompensated with 
a Child-Turcotte-Pugh (CTP) score of  8, and four 
compensated with a CPT score of  5], and five with CHB 
(all biopsy proven), and two had HCC. Of  the 12, eight 
were HBeAg-positive and the remaining four were anti-
HBe positive. The EcoRI restriction enzyme site was 
present in seven of  the full-length sequences, whereas it 
was absent in five. All sequences had a nucleotide (nt.) 
length of  3182 except genotype A sequence, which had 
3221 nt.
Distribution of genotypes
Phylogenetic analysis using complete HBV genomes of  
genotypes A to H derived from GenBank revealed the 
presence of  genotype A and D in the study population. 
Genotype D was predominant, accounting for 92% of  
the study patients (Figure 1). The nature of  genotype 
D was confirmed by the presence of  a 33-bp deletion 
in the preS1 and a 6-bp deletion in the core terminal 
regions. Whereas in the genotype A sequence, the 33-bp 
and 6 bp deletions were absent. Phylogenetic analysis of  
the core revealed the same results as analysis done with 
complete HBV genomes as shown in Figure 1A and C.
Presence of A and D genotype recombination
Phylogenetic analysis of  preS2/surface region of  12 
isolates revealed clustering of  three more sequences in 
addition to isolate 60 in the genotype A branch (Figure 
1B). Presence of  recombination was confirmed by 
boot scanning SimPlot analysis; all the sequences were 
subjected to analysis using the consensus sequence 
of  genotype A, D and H as the out-group as shown 
in Figure 2. Recombination break points, of  three 
recombinant strains were detected in preS2 and surface 
ORFs. Isolate 113 had break points at nt 595-618; isolate 
105 had break points at nt 639-659 and 723-737. Isolate 
103 had break points at nt 319-359 and 1170-1184. PreS2 
and surface regions showed similarity with genotype A at 
18 amino acid positions in the recombinant sequences, 
whereas it was absent in the surface, core and X ORFs. 
Four of  them were identified in the preS2, whereas 13 in 
the surface region, as shown in Figure 3A and B.
Major hydrophilic and the “a” determinant regions
As shown in Figure 3C, when analyzed considering 
only genotype D, the major hydrophilic region (MHR) 
showed substitutions at 10 amino acid positions. Of  the 
10 changes, five spanned the “a” determinant region. 
When similar analysis was done considering genotype 
A, we could detect a single mutation in isolate 113 at 
position 144, changing threonine to methionine in the 
“a” determinant region of  the surface region. All the 
isolates showed the presence of  concomitant threonine 
to proline change at position 131 of  the “a” determinant 
region, which is homologous to the genotype A 
sequence.
Sequence characteristics of precore/ core and X ORFs
Among the 12 patients, precore stop codon mutation 
(W28Stop) was found in two patients, and both belonged 
to the recombinant genotype. We could document 
the difference in the core nucleotide sequences in the 
recombinant sequences; however, they were not exactly 
similar to the typical genotype A pattern. We detected 
the presence of  T1936C nucleotide mutation in the core 
gene in one of  the HCC patients, isolate number 113.
X ORF: In two patients, we detected mutations in X 
ORF. Both belonged to the recombinant genotype, i.e. 
isolate 113 mutations were detected at three positions 
I127T, K130M, V131I, and isolate 105 was harboring a 
single mutation at position I127L. 
DISCUSSION
Phylogenetic analysis based on two different genomic 
regions, preS2/surface and core, suggested the existence 
Table 2  Baseline characteristics of patients
Patient No. 1 2 3 4 5 6 7 8 9 10 11 12
Age (yr) 8 24 20 20 30 29 88 38 45 40 62 50
Gender M F M M M M M F M M M M
Diagnosis CHB CHB CHB CHB CHB Cirr. Cirr. Cirr. Cirr. Cirr. HCC HCC
Bilirubin (mg/dL)     1.1       0.68      1.1      0.6      1.1   1     0.8     0.4     2.1      1.4      0.9      1.2
ALT (IU/L)       46 54 42 59 52 107 78 29 101 98 31 43
Albumin (g/dL) 4     4.1      4.3      4.8      4.3   4     2.2     3.9     3.0      3.7      4.1   4
PT prolongation (s) 2   2   1   1   2   4   4 18   8   5   2   2
Ascites No No No No No No No No Yes No No No
Encephalopathy No No No No No No No No No No No No
CTPscore 5   5   5   5   5   6   8   7   9   6   5   5
HBeAg Pos Pos Pos Pos Pos Pos Pos Neg Neg Pos Pos Neg
HBV DNA (log copies/mL)   5.4     5.6      6.4      7.2      5.6     6.4     4.9     5.1     5.7      6.1      5.3      6.5
HAI 2   5   6   6   5   -   -   -   -   -   -   -
F Score 1   1   1   3   2   -   -   -   -   -   -   -
Cirr: Cirrhosis; ALT: Alanine aminotransferase; PT: Prothrombin time; CTP: Child-Turcotte-Pugh; HAI; Histological activity index; F: Fibrosis.
www.wjgnet.com








































































































































































































































































































































Figure 1  Phylogenetic tree revealed the distribution of genotypes. A: Neighbor joining (NJ) phylogenetic tree was constructed based on the complete genome 
sequences of 26 HBV reference strains from DDBJ/EMBL/Genbank and 12 Indian HBV isolates in the present study. The bootstrap values obtained from 1000 
replicas are shown at the nodes of the main branches. HBV strains from this study are marked as Ran as suffix followed by the isolate number. Reference sequences 
are denoted by their accession numbers. The capital letter A to H denotes the HBV genotype; B: Phylogenetic analysis done on the PreS2 and surface regions 
showing three additional (103,105,113) isolates to be grouped in genotype A branch. Phylogenetic trees were constructed by NJ Kimura two-parametric method. 
Bootstrap values are shown at the nodes of the main branch and at the bottom distance is given; C: Phylogenetic analysis using the Core region. Phylogenetic tree 
was constructed by NJ Kimura 2-parametric method Bootstrap values are shown at the nodes of the main branch and at the bottom distance given.

























































































Figure 2  SimPlot analysis demonstrating the recombination in two isolates 103 and105, which were subjected to bootscan analysis over the entire 
genome using SimPlot program (Lole et al[18]).
of  recombinant strains in Indian isolates of  HBV. 
On examination of  the preS2 and the surface region 
sequences, a close relation with genotype A sequence 
was detected in three genotype D sequences respective 
to core, which was genotype D. Further analysis of  
corresponding genomes allowed us to map the crossover 
www.wjgnet.com
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Figure 3  Recombinant sequence similarities with genotype A in PreS2 and Surface region. 
A: Surface region alignment with genotype A and D amino acids, marked in red shows all three 
recombinant sequences having similarity with genotype A, whereas yellow marked amino acids shows 
at least one recombinant sequence similar to genotype A, over all 18 positions; B: Shows same in the 
preS2 region; C: Shows all the amino acids of MHR of genotype D in black, upward arrow indicates 
































junctions and to confirm the findings of  recombination.
HBV recombination is not a new phenomenon, 
i t i s impor tant from an evolut ionar y as wel l as 
epidemiological point of  view. As increasing number of  
full-length HBV genome sequences are reported, and 
a higher frequency of  recombinant hybrid genomes is 
being recognized. Evidence of  HBV recombination from 
different parts of  the world suggests the presence of  
recombination of  HBV genotypes involving A/C, A/D, 
A/E, B/C, B/D, G/A and G/C strains[20-23]. In Asia, 
recombination of  genotype C/D has been reported 
from Tibet and China[21,23], whereas recombination of  
B and C has been detected in Japan[24]. HBV strains 
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recombination of  C and A genotypes[25]. Genotype 
A and D recombination has only been documented 
in CHB patients from South Africa[26]. Although the 
recombination of  A and D genotypes has been detected 
from Italian and Indian HBV strains, such patients were 
surface-antigen negative[7]. Furthermore, breakpoints 
of  recombination were different from the presently 
identified recombinant strains[27,28].
A switch in genotype has been documented during 
change of  HBsAg-positive to serologically negative 
phase[29]. As we detected recombination in the preS2/
surface coding region, we focused on the major 
hydrophilic region, “a” determinant region of  surface 
ORF, speculating that the changes in the MHR and the 
“a” determinant region could lead to absence of  the 
surface antigen, using standard serological methods. Our 
analysis revealed changes at 11 amino acid positions when 
the analysis was done using genotype D (Figure 3C). 
When the analysis was carried out considering both 
A and D genotypes, we could detect changes at only 
a single position substituting (K) lysine with (M) 
methionine in the “a” determinant region. However, 
the amino acid substitutions that are supposed to alter 
the conformation of  “a” determinant region were not 
found.
Compared to genotype D, genotype A is more 
prevalent in the HBeAg-positive than in the anti-HBe-
positive phase[30,31]. It is known that HBV genotype D 
virus has a selection advantage to form the precore stop 
codon mutation, as compared to the genotype A virus, 
the selection being at the pre-genome encapsidation 
level. However, in the recombinant sequences identified 
in the present study, we detected the precore stop codon 
mutation in two of  them. The presence of  the stop 
codon in the precore region and co-infection with other 
genotypes A, C and H are two important features of  
HBV genotype G[32]. In presently identified recombinant 
sequences, we detected the presence of  Pc G1896A, and 
this suggests a possible similar situation and a matter for 
further investigation.
Recent reports suggest the presence of  mixed 
genotypes in Asia. Europe and Africa in CHB patients, 
including India[9,11,33]. Moreover, higher levels of  HBV 
replication have been shown to be associated with mixed 
genotype infection[33].
It is quite possible that the PreS, core, X and P 
proteins are continually expressed but the preS2 region/
protein of  genotype D is lost for a short interval during 
recombination with genotype A sequences, mimicking a 
molecular window period. It is not yet known whether 
recombination is advantageous for the virus or the host, 
but it is quite possible that this phenomenon increases 
the chances of  virus survival and doping the host 
defense system.
One of  the reasons for enhanced HCC development 
in young African adults could be high HBsAg expression 
in genotype-A-harboring patients[34] HBV genotype 
A directs the high level of  synthesis of  HBsAg in 
proportion to viral DNA, core protein and HBeAg[35].
The frequency of  detect ion of  spl iced vira l 
genomes is higher in CHB cases compared to acute 
and resolved HBV infections. The generation of  
recombinant HBV could be intracellular, as the ratio 
of  full-length and spliced genomes isolated from the 
intracellular compartment was significantly higher than 
from extracellular space. This indicates that, compared 
to those containing spliced genomes, nucleocapsids 
containing full-length genomes are preferentially 
enveloped and released from the cell, and could be one 
of  the reasons for severe liver disease[36]. It would be 
worth while to study the co-infection of  two genotypes, 
and to establish whether the changes accumulate in 
one cell or together in the newly infected cells. Genetic 
exchanges between different viral strains within the 
infected hepatocytes could be one of  the possible 
reasons for recombination.
HBV infection is the predominant factor for the 
development of  HCC in India[37]. Several reports suggest 
integration of  the preS/S region in cancerous liver 
tissue[38-40]. Binding of  the PreS region with fibronectin 
and transactivation of  TGF a could lead to development 
of  cirrhosis and HCC[41-43]. It is quite unique that HBV 
uses its strongest promoter preS2/S for expression of  
the host cellular genes, which are advantageous for the 
virus itself.
HBV recombinant sequences were analyzed with the 
orangutan and gibbon monkey hepatitis virus. However, 
we could not find any association of  recombinant 
sequences wi th them, and the reason for such 
transmission was clarified (data not shown). Secondly, 
phylogenetic analysis was done using the Italian and 
Indian recombinant sequences reported previously[27,28]. 
However, they were not clustering in the same region as 
detected in the present recombinant sequences (data not 
shown).
There are three theories proposed for evolution 
of  HBV: The new world origin theory[5], co-evolution 
theory[3,44] and co-speciated theory[45,46]. We postulate a 
competitive selection theory in which the virus and the 
host cellular machinery compete, and involvement of  
various unidentified ways by the virus to combat the 
host defense mechanisms. A few of  these could be the 
splicing, integration, recombination and down-regulation 
of  MHC Ⅰ. On the other hand, host APOBEC response 
to edit the viral genome, CTL proteosome complex and 
various host genetic factors, taking into consideration 
ethnicity, may play a part as well. Recombinant detection 
of  mixed genotypes, however, may be the tip of  the 
iceberg as a template switch over, splicing and extensive 
editing by all APOBEC 3 proteins, which have not been 
well studied.
It can be argued that, in our study, the HBV 
sequences were analyzed only at one stage of  the disease, 
the process of  sequential changes and the time points 
were not tracked. This was a preliminary study and such 
studies are quite cumbersome and expensive.
In summary, we identified new A/D recombinants 
from Indian CLD and HCC patients. To the best of  
our knowledge, this is the first report which describes 
recombinant A and D genotype from HBsAg-positive 
www.wjgnet.com
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patients from Asia, and indicates the association of  
recombinant HBV genotype with HCC. The results 
of  the present study warrants further larger studies to 
identify populations of  recombinant viruses in different 
clinical categories of  HBV patients.
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